USPTO ignites CRISPR/Cas9 patent battle

Scientists from two US universities will fight out the ownership of the intellectual property rights to the CRISPR/Cas9 technology after the US Patent and Trademark Office (USPTO) agreed to initiate an interference proceeding.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Squires refuses to resurrect HydraFacial patent review

22 April 2026 Decision underscores a growing deference to parallel rulings and tighter control over duplicate patent challenges.

Americas

Penile implant maker’s $17m trade secret award unravels

20 April 2026 The maker of a cosmetic penile implant has suffered at the Federal Circuit, after a ruling said its trade secrets claims are not protectable while leaving a counterfeiting finding intact.

Americas

Appeals court eases Teva’s headache with reversal

17 April 2026 A ruling that invalidated three of Teva's headache treatment patents has been thrown out, sending a long-running case back to the lower court.

More features

Squires refuses to resurrect HydraFacial patent review

Litigator from Brown Rudnick moves firms to chair practice

INTA 2026: In-house tips on what to do in London

Penile implant maker’s $17m trade secret award unravels

Appeals court eases Teva’s headache with reversal

Simmons & Simmons makes senior Asia trademark hire

Baker McKenzie strengthens IP bench with new German lead

Cancer drug researcher hit with suit over mutation-targeting tools

USPTO ignites CRISPR/Cas9 patent battle

More on this story

Editor's picks

Editor's picks

More features